Stacks and blends

    Foundation stack (to start)

    Sermorelin & Ipamorelin — dual GH pulse

    🎉 10% off all blends
    1.650.000 ₫

    1.485.000 ₫

    Vial-by-vial breakdown

    Sermorelin (5mg)1.100.000 ₫
    Ipamorelin (5mg)550.000 ₫
    Subtotal1.650.000 ₫
    Stack discount (10%)−165.000 ₫

    The gentlest GH-axis stack in the lineup. Sermorelin is a GHRH(1-29) fragment — the shortest, most physiologic GHRH analog available, with a 10–20 min half-life that produces a single small endogenous GH pulse rather than the sustained 'GH bleed' of longer-acting GHRHs like CJC-1295 DAC or Tesamorelin. Ipamorelin is the only GHRP with documented zero effect on cortisol, prolactin or aldosterone at clinical doses, and unlike GHRP-6 or Hexarelin it does not stimulate appetite or cause receptor desensitisation. Combined, they trigger a stronger, cleaner endogenous GH pulse than either alone — closer to the natural burst seen in young, healthy adults. The most common starting point for first-time users.

    Dosage

    Start Sermorelin 100–150 µg + Ipamorelin 100 µg nightly; after 1 week double to Sermorelin 200–300 µg + Ipamorelin 200 µg nightly

    Duration of effect

    Sermorelin ~10–20 min · Ipamorelin ~2 hours (GH pulse 1–3 h)

    See full half-life table →

    Key Features

    • Dual-receptor GH pulse (GHRH + GHSR)
    • No cortisol or prolactin spike
    • Recovery, sleep & lean mass
    • 10% stack discount
    Contact Us

    Includes key details, half-life data, usage notes and research sources.

    Usage Instructions

    Subcutaneous injection as recommended. Consult a healthcare professional for protocols tailored to your goals.

    Research Highlights

    • Backed by scientific research
    • Manufactured to pharmaceutical standards
    • Used in clinical research settings
    • Established safety profile

    Safety Information

    • •Consult your healthcare provider before use
    • •Not intended for pregnant or nursing women
    • •Store properly according to instructions
    • •Report any adverse effects to your healthcare provider

    Source: European Journal of Endocrinology — Ipamorelin, the first selective GH secretagogue

    Clinical Research

    Co-administration of a GHRH analog with a selective GH secretagogue (ipamorelin) produces a synergistic GH release significantly greater than either compound alone, without elevating cortisol or prolactin.

    Read full study

    Additional Research

    Source: Annals of the New York Academy of Sciences — GHRH and Sermorelin in adults

    Sermorelin acetate, a GHRH(1-29) analog, restores physiologic GH pulsatility and increases IGF-1 in adults with reduced GH output, improving body composition, sleep quality and exercise capacity.

    Read full study

    Human Clinical Trials

    • Ipamorelin after bowel surgeryInternational Journal of Colorectal Disease · 2014

      Randomised placebo-controlled trial in 117 patients: faster recovery of gut function after bowel resection.

      Read the trial
      117
      participants
    See the full trial library

    Related Products